Axpharmsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2008-06-27
Share capital
50 000,00 PLN
Activity description

Axpharm, founded in 2008, focuses on research and development of medical devices and dietary supplements. It designs and manufactures ear, throat and nasal sprays, as well as supplements containing vitamins A and E. The company offers private-label contract manufacturing and sells its products internationally through distributors.

Registered address
ul. Hermana Frankego 5A, 85-862 Bydgoszcz, Poland
Website
axpharm.euWebsite active
Electronic delivery address
AE:PL-14286-48008-UCUIB-25

Financials

Revenue history (in k)

Financial insight

  • companies.financials.estonianCitCertain

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.61mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 341.15kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 1.27mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 1.43mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2008-07-22. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,167
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$7,748
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,057

Tenders

No recorded participation in tenders.

Trademarks

Axpharm holds 10 active trademarks registered with the Polish Patent Office. 8 marks have expired or were not registered. The first mark was filed in 2011.

MarkProtected until
Otibur(word)Dec 17, 2029
Axibur(word)Dec 17, 2029
ringosol(word)Sep 25, 2028
cerumex(word)Sep 25, 2028
AloeNasin(word)Oct 23, 2027

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Michał Andrzej Ławicki – President of the Management Board

Manner of representation

Independent representation.

Ownership

OwnerSharesShare valueStake
Lucyna Danuta Ławicka (56)
44$11,885.4788%
Others
6$1,620.7512%

Beneficial owners

Person

Competitors

Name
Przedsiębiorstwo Produkcyjno-Handlowo-Usługowe Achimaxsp. z o.o.
Activepharm Labssp. z o.o.
Axfarmsp. z o.o.
Steriwundsp. z o.o.
Farmbudsp. z o.o.
Citipharmsp. z o.o. + limited partnership
AVEC Pharmasp. z o.o.
Auspolsp. z o.o.
Atradis Polskasp. z o.o.
Aprodsp. z o.o.

Change history

DateEvent
2022-03-17PKD change
2021-03-18Address change
2008-06-27Entered in the register

FAQ

Last updated: 2026-04-16